» Articles » PMID: 29499948

Endogenous Cellular MicroRNAs Mediate Antiviral Defense Against Influenza A Virus

Overview
Publisher Cell Press
Date 2018 Mar 4
PMID 29499948
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

The reciprocal interaction between influenza virus and host microRNAs (miRNAs) has been implicated in the regulation of viral replication and host tropism. However, the global roles of the cellular miRNA repertoire and the mechanisms of miRNA-mediated antiviral defense await further elucidation. In this study, we systematically screened 297 cellular miRNAs from human and mouse epithelial cells and identified five inhibitory miRNAs that efficiently inhibited influenza virus replication in vitro and in vivo. Among these miRNAs, hsa-mir-127-3p, hsa-mir-486-5p, hsa-mir-593-5p, and mmu-mir-487b-5p were found to target at least one viral gene segment of both the human seasonal influenza H3N2 and the attenuated PR8 (H1N1) virus, whereas hsa-miR-1-3p inhibited viral replication by targeting the supportive host factor ATP6V1A. Moreover, the number of miRNA binding sites in viral RNA segments was positively associated with the activity of host miRNA-induced antiviral defense. Treatment with a combination of the five miRNAs through agomir delivery pronouncedly suppressed viral replication and effectively improved protection against lethal challenge with PR8 in mice. These data suggest that the highly expressed miRNAs in respiratory epithelial cells elicit effective antiviral defenses against influenza A viruses and will be useful for designing miRNA-based therapies against viral infection.

Citing Articles

Therapeutic effects of platelet-derived extracellular vesicles on viral myocarditis correlate with biomolecular content.

Beetler D, Giresi P, Di Florio D, Fliess J, McCabe E, Watkins M Front Immunol. 2025; 15():1468969.

PMID: 39835120 PMC: 11743460. DOI: 10.3389/fimmu.2024.1468969.


miR-191-5p suppresses PRRSV replication by targeting porcine EGFR to enhance interferon signaling.

Pan Y, Zhang L, Ma W, Ibrahim Y, Zhang W, Wang M Front Microbiol. 2024; 15:1473504.

PMID: 39469460 PMC: 11514493. DOI: 10.3389/fmicb.2024.1473504.


Recent advances in understanding of the mechanisms of RNA interference in insects.

Koo J, Palli S Insect Mol Biol. 2024; .

PMID: 38957135 PMC: 11695441. DOI: 10.1111/imb.12941.


Influenza Virus Host Restriction Factors: The ISGs and Non-ISGs.

Husain M Pathogens. 2024; 13(2).

PMID: 38392865 PMC: 10893265. DOI: 10.3390/pathogens13020127.


COVID-19 Vaccination in Pregnancy: Pilot Study for Maternal and Neonatal MicroRNA Profiles.

Chen W, Hu S, Shen C, Cheng M, Hong J, Shen C Vaccines (Basel). 2023; 11(12).

PMID: 38140218 PMC: 10747030. DOI: 10.3390/vaccines11121814.


References
1.
Ingle H, Kumar S, Raut A, Mishra A, Kulkarni D, Kameyama T . The microRNA miR-485 targets host and influenza virus transcripts to regulate antiviral immunity and restrict viral replication. Sci Signal. 2015; 8(406):ra126. DOI: 10.1126/scisignal.aab3183. View

2.
Song L, Liu H, Gao S, Jiang W, Huang W . Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J Virol. 2010; 84(17):8849-60. PMC: 2919005. DOI: 10.1128/JVI.00456-10. View

3.
Bogerd H, Skalsky R, Kennedy E, Furuse Y, Whisnant A, Flores O . Replication of many human viruses is refractory to inhibition by endogenous cellular microRNAs. J Virol. 2014; 88(14):8065-76. PMC: 4097787. DOI: 10.1128/JVI.00985-14. View

4.
Trobaugh D, Klimstra W . MicroRNA Regulation of RNA Virus Replication and Pathogenesis. Trends Mol Med. 2016; 23(1):80-93. PMC: 5836316. DOI: 10.1016/j.molmed.2016.11.003. View

5.
Huntzinger E, Izaurralde E . Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet. 2011; 12(2):99-110. DOI: 10.1038/nrg2936. View